Device Trial Radar · NCT06865755
Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- San Diego State UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Virginia; National Cancer Institute (NCI)
- First posted
- Mar 10, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- Female only, from 21 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to learn about the impact of an integrated medication monitoring system in breast cancer survivors aged 21-70 who are prescribed endocrine therapy. The main question it aims to address is: Does the integrated medication monitoring system improve medication adherence among breast cancer survivors when used over a six-month period? Fifteen English-speaking breast cancer survivors who meet the inclusion criteria will use a combination of smartphone-based ecological momentary assessments, a medication event monitoring system (Wisepill), and a wearable sensor (Fitbit). After 2 months, participants will be provided personalized content to facilitate medication adherence through an app (Digital Trails) and through WisePill. Participants will complete online surveys at baseline, 3 months, and 6 months to assess their experiences and adherence.
Conditions
- Breast Cancer Survivor
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Interventions
integrated medication monitoring (MM) systemDevice
We have created a new integrated medication monitoring (MM) system consisting of baseline, 3-month, and 6-month surveys, smartphone-based ecological momentary assessment via an application installed on a smartphone (Digital Trails based on the UVA Sensus app), a wireless medication event monitoring system device (MEMS; Wisepill), and a wearable sensor (Fitbit), and data collected passively from smartphone sensors using the Digital Trails app. These sources of information will be used to understand predictors of medication taking behaviors and, after two months of monitoring, to deploy appropriate interventions which will be delivered via the Digital Trails app platform.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Wisepill MEMS Sensor data collectionTime frame: From enrollment to the end of study at 6 months
25 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
San Diego State University
San Diego, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.